Onesource Specialty Pharma share news, announcements and annual reports
NSE: ONESOURCEBSE: 544292Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,577.60.
29 Oct: open ₹1,585.00, high ₹1,597.60, low ₹1,564.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17,999 Cr373rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.04
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.0%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹13 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 0.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.25
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,36,95662.9% delivered
Onesource Specialty Pharma has 143 announcements on record, routine notices left out; 7 in the 30 days to 29 Oct 2026, the latest on 27 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Onesource Specialty Pharma quarterly results
The board met on 27 Oct 2026 to consider financial results
Notice filed 21 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Onesource Specialty Pharma annual reports, presentations and earnings calls
The company's own documents, latest first.Onesource Specialty Pharma financials, year by year
Annual reports2
- Annual report, year to Mar 202631 Aug 2026
- Annual report, year to Mar 202529 Aug 2025
Investor presentations6
- Investor Presentation3 Sep 2026
- Investor Presentation13 May 2026
- Investor Presentation23 Jan 2026
- Investor Presentation12 Nov 2025
- Presentation on Merger and Other restructuring26 Sep 2025
1 earlier presentation
- Investor Presentation6 May 2025
Earnings calls14
- Link of Recording27 Oct 2026
- Earnings Call Transcript dated July 25, 202631 Jul 2026
- Link of Recording25 Jul 2026
- Earnings Call Transcript dated May 13, 2026.19 May 2026
- Link of Recording13 May 2026
9 earlier call documents
- Transcript of the Earnings Call30 Jan 2026
- Link of Recording24 Jan 2026
- Transcript18 Nov 2025
- Link of Recording13 Nov 2025
- Transcript of the Earnings call held on August 05, 202512 Aug 2025
- Link of Recording5 Aug 2025
- Transcript12 May 2025
- Transcript4 Feb 2025
- Link of Audio/ Video Recordings of the investor call.30 Jan 2025
Onesource Specialty Pharma merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings1
- Amalgamation/Merger26 Sep 2025
Onesource Specialty Pharma share news and announcements
Newest first. Page 1 of 3.
Oct 2026
27 Oct · Management
21 Oct · Analysts
21 Oct · Board meeting
Sep 2026
25 Sep · Updates
23 Sep · Management
Aug 2026
31 Aug · Analysts
18 Aug · Rating
Jul 2026
27 Jul · Management
24 Jul · Updates
24 Jul · Management
24 Jul · Results
21 Jul · Analysts
8 Jul · General Updates
Jun 2026
May 2026
13 May · General Updates
13 May · Results
7 May · Analysts
7 May · Board meeting
Apr 2026
28 Apr
9 Apr · General Updates
Mar 2026
4 Mar · Analysts
Feb 2026
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 27 Oct 2026Resultsup 13.78%+13.2 pts vs Nifty 500market median −0.7% · volume 36.1× usual · delivery −36.9 pts against usual · The announcement
- 18 Aug 2026Credit ratingdown 1.02%−0.6 pts vs Nifty 500market median 0.0% · five sessions −1.7% (−1.5 pts vs Nifty 500) · volume 0.9× usual · delivery +16.5 pts against usual · The announcement
- 28 Jul 2026Board or managers changedup 2.51%+2.7 pts vs Nifty 500market median 0.0% · five sessions −7.6% (−10.4 pts vs Nifty 500) · volume 1.2× usual · delivery −0.8 pts against usual · The announcement
- 27 Jul 2026Resultsup 2.12%+1.1 pts vs Nifty 500market median −0.7% · five sessions −2.1% (−4.5 pts vs Nifty 500) · volume 2.3× usual · delivery −2.4 pts against usual · The announcement
- 27 Jul 2026Board or managers changedup 2.12%+1.1 pts vs Nifty 500market median 0.0% · five sessions −2.1% (−4.5 pts vs Nifty 500) · volume 2.3× usual · delivery −2.4 pts against usual · The announcement
- 13 May 2026Resultsdown 2.21%−2.6 pts vs Nifty 500market median −0.7% · five sessions +1.3% (+0.3 pts vs Nifty 500) · volume 0.4× usual · delivery −18.7 pts against usual · The announcement
- 13 May 2026Board or managers changeddown 2.21%−2.6 pts vs Nifty 500market median 0.0% · five sessions +1.3% (+0.3 pts vs Nifty 500) · volume 0.4× usual · delivery −18.7 pts against usual · The announcement
- 6 Mar 2026Credit ratingup 3.95%+4.9 pts vs Nifty 500market median 0.0% · five sessions +3.2% (+6.7 pts vs Nifty 500) · volume 1.3× usual · delivery +14.1 pts against usual · The announcement
- 27 Jan 2026Resultsdown 19.62%−20.1 pts vs Nifty 500market median −0.7% · five sessions −15.6% (−15.1 pts vs Nifty 500) · volume 19.0× usual · delivery −12.3 pts against usual · The announcement
- 12 Nov 2025Resultsup 0.33%−0.3 pts vs Nifty 500market median −0.7% · five sessions −1.5% (−2.1 pts vs Nifty 500) · volume 0.7× usual · delivery −8.2 pts against usual · The announcement
7 earlier announcements
- 5 Aug 2025Resultsdown 1.16%−0.9 pts vs Nifty 500market median −0.7% · five sessions −1.2% (−0.2 pts vs Nifty 500) · volume 1.9× usual · delivery −8.7 pts against usual · The announcement
- 4 Jun 2025Credit ratingup 4.13%+3.7 pts vs Nifty 500market median 0.0% · five sessions +8.2% (+5.5 pts vs Nifty 500) · volume 0.9× usual · delivery +5.8 pts against usual · The announcement
- 6 May 2025Resultsdown 1.92%−0.8 pts vs Nifty 500market median −0.7% · five sessions −4.1% (−5.5 pts vs Nifty 500) · volume 2.9× usual · delivery −5.5 pts against usual · The announcement
- 3 Mar 2025Board or managers changedup 7.15%+7.1 pts vs Nifty 500market median 0.0% · five sessions +14.6% (+11.8 pts vs Nifty 500) · volume 0.6× usual · delivery −7.6 pts against usual · The announcement
- 24 Feb 2025Board or managers changedup 2.86%+3.9 pts vs Nifty 500market median 0.0% · five sessions +4.1% (+8.0 pts vs Nifty 500) · volume 0.4× usual · delivery −1.1 pts against usual · The announcement
- 24 Feb 2025Credit ratingup 2.86%+3.9 pts vs Nifty 500market median 0.0% · five sessions +4.1% (+8.0 pts vs Nifty 500) · volume 0.4× usual · delivery −1.1 pts against usual · The announcement
- 29 Jan 2025Resultsup 4.32%+2.8 pts vs Nifty 500market median −0.7% · five sessions −2.9% (−5.2 pts vs Nifty 500) · The announcement
Onesource Specialty Pharma results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.